MBF Therapeutics, Inc. — Form D/A
MBF Therapeutics, Inc. of AMBLER, PA, a company, filed a Form D amendment with the SEC on 2010-03-15. The offering totals $1.0M, of which $345K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-03-15
- Form: D/A
- Accession: 0001458729-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $1.0M
- Amount sold: $345K
- Remaining: $665K
- Minimum investment: $50K
- Investors: 7
- Date of first sale: 2009-03-05
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-128081
Issuer
- Name: MBF Therapeutics, Inc.
- CIK: 0001458729
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2008
- Address: 640 WOODBROOK DRIVE, AMBLER, PA, 19002
- Phone: (215)620-3699
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Christopher M Ragland | Director | Ambler, PA |
| CHRISTOPHER CASHMAN | Director | COLUMBIA, SC |
| Dhiren Thakker | Director | Ambler, PA |
| Joseph Connor | Director | Ambler, PA |
| Aris Persidis | Director | Ambler, PA |
| Lorraine Keller | Executive Officer | Ambler, PA |
| Thomas Tillett | Director | Ambler, PA |
| Thomas Tillett | Executive Officer | Ambler, PA |
| Aris M Persidis | Director | Ambler, PA |
| Dhiren M Thakker | Director | Ambler, PA |
| Chris M Bunge | Director | Ambler, PA |
| Christopher M Cashman | Director | Bedford, MA |
| Christopher Ragland | Director | Ambler, PA |
Other filings by this issuer (8)
More